Stoneridge (SRI) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts SRI Hot Sheet
Price: $7.06 +2.02%
Financial Fact:
Diluted weighted average shares outstanding: 28.36M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted weighted average shares outstanding: 28.36M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Stoneridge (NYSE: SRI) reported Q3 EPS of $0.10, $0.08 better than the analyst estimate of $0.02. Revenue for the quarter came in at $237.2 million versus the consensus estimate of $237.7 million.
GUIDANCE:
Stoneridge sees FY2023 EPS of ($0.10)-$0.00, versus the consensus of ($0.26). Stoneridge sees FY2023 revenue of $965-975 million, versus the consensus of $984.7 million.
For earnings history and earnings-related data on Stoneridge (SRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
